LONDON, May 23, 2005 (PRIMEZONE) -- Antisoma plc (LSE:ASM) today announces that its Chief Executive Officer, Glyn Edwards, will be presenting at the Needham & Company Fourth Annual Biotechnology Conference in New York, USA.
Mr. Edwards's presentation is scheduled for 14.30 EST on Thursday, May 26, with an additional breakout session at 15.00. A webcast of the presentation will be available to all on Antisoma's website at www.antisoma.com
It is recommended that viewers log on 15 minutes early in order to register and download any necessary software. If you are unable to participate during the live web cast, a recorded replay of the presentation will be available for 90 days.
Enquiries: Margherita Lupi +44 (0)20 8799 8200 Corporate Communications Manager Antisoma plc
Background on Antisoma
Antisoma is a biopharmaceutical company that develops novel products for the treatment of cancer. Antisoma fills its development pipeline by acquiring promising new product candidates from internationally recognised academic or cancer research institutions. Its core activity is the preclinical and clinical development of these drug candidates. In November 2002, Antisoma formed a broad strategic alliance with Roche to develop and commercialise products from Antisoma's pipeline. Please visit www.antisoma.com for further information.